Update on Chemotherapy in the Treatment of Urothelial Carcinoma

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort

(2011) Robert S. Svatek et al.   BJU INTERNATIONAL

Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer

(2011) Ananya Choudhury et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]

(2010) P. Albers et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder

(2010) R. S. Svatek et al.   CLINICAL CANCER RESEARCH

Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer

(2010) Nathan Lawrentschuk et al.   EUROPEAN UROLOGY

Phase II Study of Sunitinib in Patients With Metastatic Urothelial Cancer

(2010) David J. Gallagher et al.   JOURNAL OF CLINICAL ONCOLOGY

Do Patients With Advanced Urothelial Carcinoma Benefit From Weekly Paclitaxel Chemotherapy? A GETUG Phase II Study

(2009) Florence Joly et al.   Clinical Genitourinary Cancer

Combination of Gemcitabine and Paclitaxel as Second-line Chemotherapy for Advanced Urothelial Carcinoma

(2009) T. Suyama et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract

(2009) Joaquim Bellmunt et al.   JOURNAL OF CLINICAL ONCOLOGY

A Randomized Phase II Trial Assessing in Advanced Non-small Cell Lung Cancer Patients with Stable Disease after Two Courses of Cisplatin-Gemcitabine an Early Modification of Chemotherapy Doublet with Paclitaxel-Gemcitabine Versus Continuation of Cisplatin-Gemcitabine Chemotherapy (GFPC 03-01 Study)

(2009) Alain Vergnenègre et al.   Journal of Thoracic Oncology

Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802)

(2008) Robert Dreicer et al.   CANCER

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder

(2008) Atreya Dash et al.   CANCER

Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy

(2008) Kunimitsu Kanai et al.   International Journal of Clinical Oncology

Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy

(2008) Donald S. Kaufman et al.   UROLOGY